Article
Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Scientific reports - 23 May 2024
Li Junhang, Ma Xiang, Yin Cuihua
Abstract excerpt
Nonalcoholic fatty liver disease (NAFLD) is the predominant cause of liver pathology. Current evidence highlights plasma proteins as potential therapeutic targets. However, their mechanistic roles in NAFLD remain unclear. This study investigated the involvement of specific plasma proteins and intermediate risk factors in NAFLD progression. Two-sample Mendelian randomization (MR) analysis was conducted to examine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
